Found: 65
Select item for more details and to access through your institution.
High frequency of simultaneous loss of p16 and p16β gene expression in squamous cell carcinoma of the esophagus but not in adenocarcinoma of the esophagus or stomach.
- Published in:
- Oncogene, 1997, v. 15, n. 12, p. 1481, doi. 10.1038/sj.onc.1201295
- By:
- Publication type:
- Article
Community education to enhance the more equitable use of precision medicine in Northern Manhattan.
- Published in:
- Journal of Genetic Counseling, 2020, v. 29, n. 2, p. 247, doi. 10.1002/jgc4.1244
- By:
- Publication type:
- Article
Readability of Cancer Clinical Trials Websites.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Readability of Cancer Clinical Trials Websites.
- Published in:
- Cancer Control: Journal of the Moffitt Cancer Center, 2020, v. 27, n. 1, p. 1, doi. 10.1177/1073274819901125
- By:
- Publication type:
- Article
Readability of Cancer Clinical Trials Websites.
- Published in:
- Cancer Control: Journal of the Moffitt Cancer Center, 2020, v. 27, n. 1, p. 1, doi. 10.1177/1073274819901125
- By:
- Publication type:
- Article
Preclinical study of treatment response in HCT-116 cells and xenografts with <sup>1</sup>H-decoupled <sup>31</sup>P MRS.
- Published in:
- NMR in Biomedicine, 2011, v. 24, n. 9, p. 1159, doi. 10.1002/nbm.1674
- By:
- Publication type:
- Article
TP53 mutations emerge with HDM2 inhibitor SAR405838 treatment in de-differentiated liposarcoma.
- Published in:
- Nature Communications, 2016, v. 7, n. 8, p. 12609, doi. 10.1038/ncomms12609
- By:
- Publication type:
- Article
KIT as a Therapeutic Target in Metastatic Melanoma.
- Published in:
- JAMA: Journal of the American Medical Association, 2011, v. 305, n. 22, p. 2327, doi. 10.1001/jama.2011.746
- By:
- Publication type:
- Article
Composite grading algorithm for the National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).
- Published in:
- Clinical Trials, 2021, v. 18, n. 1, p. 104, doi. 10.1177/1740774520975120
- By:
- Publication type:
- Article
Discordant attitudes and beliefs about cancer clinical trial participation between physicians, research staff, and cancer patients.
- Published in:
- Clinical Trials, 2020, v. 17, n. 2, p. 184, doi. 10.1177/1740774520901514
- By:
- Publication type:
- Article
Phase II Trial of Gemcitabine and Docetaxel with Bevacizumab in Soft Tissue Sarcoma.
- Published in:
- Sarcoma, 2015, v. 2015, p. 1, doi. 10.1155/2015/532478
- By:
- Publication type:
- Article
A Pilot Study of Anti-CTLA4 Antibody Ipilimumab in Patients with Synovial Sarcoma.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
A Pilot Study of Anti-CTLA4 Antibody Ipilimumab in Patients with Synovial Sarcoma.
- Published in:
- Sarcoma, 2013, p. 1, doi. 10.1155/2013/168145
- By:
- Publication type:
- Article
Ifosfamide May Be Safely Used in Patients with End Stage Renal Disease on Hemodialysis.
- Published in:
- 2009
- By:
- Publication type:
- Case Study
PMA-induced reduction in invasiveness is associated with hyperphosphorylation of MARCKS and talin in invasive bladder cancer cells.
- Published in:
- International Journal of Cancer, 1998, v. 75, n. 5, p. 774, doi. 10.1002/(SICI)1097-0215(19980302)75:5<774::AID-IJC18>3.0.CO;2-6
- By:
- Publication type:
- Article
The mutational status of p53 protein in gastric and esophageal adenocarcinoma cell lines predicts sensitivity to chemotherapeutic agents.
- Published in:
- International Journal of Cancer, 1995, v. 64, n. 1, p. 37, doi. 10.1002/ijc.2910640109
- By:
- Publication type:
- Article
Early treatment-related neutropenia predicts response to palbociclib.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Selective inhibition of cyclooxygenase-2 enhances mitomycin-C-induced apoptosis.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2000, v. 45, n. 5, p. 389, doi. 10.1007/s002800051007
- By:
- Publication type:
- Article
Correction to: Missing data strategies for the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in Alliance A091105 and COMET-2.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Missing data strategies for the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in Alliance A091105 and COMET-2.
- Published in:
- Quality of Life Research, 2022, v. 31, n. 4, p. 1069, doi. 10.1007/s11136-021-02968-1
- By:
- Publication type:
- Article
Down-regulation of the tumor suppressor miR-34a contributes to head and neck cancer by up-regulating the MET oncogene and modulating tumor immune evasion.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2021, v. 40, n. 1, p. 1, doi. 10.1186/s13046-021-01865-2
- By:
- Publication type:
- Article
A Phase I Dose-Escalation Study of LY3405105, a Covalent Inhibitor of Cyclin-Dependent Kinase 7, Administered to Patients With Advanced Solid Tumors.
- Published in:
- Oncologist, 2024, v. 29, n. 1, p. e131, doi. 10.1093/oncolo/oyad215
- By:
- Publication type:
- Article
A Phase II Trial of Sorafenib and Dacarbazine for Leiomyosarcoma, Synovial Sarcoma, and Malignant Peripheral Nerve Sheath Tumors.
- Published in:
- Oncologist, 2019, v. 24, n. 6, p. 857, doi. 10.1634/theoncologist.2018-0160
- By:
- Publication type:
- Article
A Phase Ib/II Study of Gemcitabine and Docetaxel in Combination With Pazopanib for the Neoadjuvant Treatment of Soft Tissue Sarcomas.
- Published in:
- Oncologist, 2015, v. 20, n. 11, p. 1245, doi. 10.1634/theoncologist.2015-0245
- By:
- Publication type:
- Article
Ipilimumab for Patients With Advanced Mucosal Melanoma.
- Published in:
- Oncologist, 2013, v. 18, n. 6, p. 726, doi. 10.1634/theoncologist.2012-0464
- By:
- Publication type:
- Article
Impact of Combined mTOR and MEK Inhibition in Uveal Melanoma Is Driven by Tumor Genotype.
- Published in:
- PLoS ONE, 2012, v. 7, n. 7, p. 1, doi. 10.1371/journal.pone.0040439
- By:
- Publication type:
- Article
A phase 2 study of MK‐2206 in patients with incurable adenoid cystic carcinoma (Alliance A091104).
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 5, p. 702, doi. 10.1002/cncr.35103
- By:
- Publication type:
- Article
Alliance A151945: Accrual and characteristics of adolescent and young adult patients in Alliance trials from 2000 to 2017.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 5, p. 750, doi. 10.1002/cncr.35078
- By:
- Publication type:
- Article
IGF2 over-expression in solitary fibrous tumours is independent of anatomical location and is related to loss of imprinting.
- Published in:
- Journal of Pathology, 2010, v. 221, n. 3, p. 300, doi. 10.1002/path.2715
- By:
- Publication type:
- Article
Phase 1 trial of navitoclax and sorafenib in patients with relapsed or refractory solid tumors with hepatocellular carcinoma expansion cohort.
- Published in:
- Investigational New Drugs, 2024, v. 42, n. 1, p. 127, doi. 10.1007/s10637-024-01420-8
- By:
- Publication type:
- Article
Genetic analysis of the 'uveal melanoma' C918 cell line reveals atypical BRAF and common KRAS mutations and single tandem repeat profile identical to the cutaneous melanoma C8161 cell line.
- Published in:
- Pigment Cell & Melanoma Research, 2015, v. 28, n. 3, p. 357, doi. 10.1111/pcmr.12345
- By:
- Publication type:
- Article
Clinical trial enrollment of adolescents and young adults with sarcoma.
- Published in:
- Cancer (0008543X), 2017, v. 123, n. 18, p. 3434, doi. 10.1002/cncr.30757
- By:
- Publication type:
- Article
Patient-derived xenografts for individualized care in advanced sarcoma.
- Published in:
- Cancer (0008543X), 2014, v. 120, n. 13, p. 2006, doi. 10.1002/cncr.28696
- By:
- Publication type:
- Article
Clinical activity of ipilimumab for metastatic uveal melanoma: a retrospective review of the Dana-Farber Cancer Institute, Massachusetts General Hospital, Memorial Sloan-Kettering Cancer Center, and University Hospital of Lausanne experience.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Clinical Activity of Ipilimumab for Metastatic Uveal Melanoma.
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 20, p. 3687, doi. 10.1002/cncr.28282
- By:
- Publication type:
- Article
Single-institution experience with ipilimumab in advanced melanoma patients in the compassionate use setting: lymphocyte count after 2 doses correlates with survival.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Single-Institution Experience With Ipilimumab in Advanced Melanoma Patients in the Compassionate Use Setting.
- Published in:
- Cancer (0008543X), 2010, v. 116, n. 7, p. 1767, doi. 10.1002/cncr.24951
- By:
- Publication type:
- Article
Chemotherapy and P-glycoprotein expression in chondrosarcoma.
- Published in:
- Journal of Orthopaedic Research, 1998, v. 16, n. 5, p. 585, doi. 10.1002/jor.1100160510
- By:
- Publication type:
- Article
Drug Synergy Screen and Network Modeling in Dedifferentiated Liposarcoma Identifies CDK4 and IGF1R as Synergistic Drug Targets.
- Published in:
- Science Signaling, 2013, v. 6, n. 294, p. 1, doi. 10.1126/scisignal.2004014
- By:
- Publication type:
- Article
Pharmacokinetics of dacarbazine and unesbulin and CYP1A2‐mediated drug interactions in patients with leiomyosarcoma.
- Published in:
- CTS: Clinical & Translational Science, 2024, v. 17, n. 2, p. 1, doi. 10.1111/cts.13709
- By:
- Publication type:
- Article
Potentiation of apoptosis by treatment with the protein kinase C-specific inhibitor safingol in...
- Published in:
- JNCI: Journal of the National Cancer Institute, 1995, v. 87, n. 18, p. 1394, doi. 10.1093/jnci/87.18.1394
- By:
- Publication type:
- Article
Protein kinase C: a novel target for inhibiting gastric cancer cell invasion.
- Published in:
- 1993
- By:
- Publication type:
- journal article
Inhibition of Invasion of Invasive Human Bladder Carcinoma Cells by Protein Kinase C Inhibitor Staurosporine.
- Published in:
- JNCI: Journal of the National Cancer Institute, 1990, v. 82, n. 22, p. 1753
- By:
- Publication type:
- Article
Intermittent MEK inhibition for the treatment of metastatic uveal melanoma.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.975643
- By:
- Publication type:
- Article
Demographics, Outcomes, and Risk Factors for Patients with Sarcoma and COVID-19: A CCC19-Registry Based Retrospective Cohort Study.
- Published in:
- Cancers, 2022, v. 14, n. 17, p. 4334, doi. 10.3390/cancers14174334
- By:
- Publication type:
- Article
A Phase Ib Study of Sotrastaurin, a PKC Inhibitor, and Alpelisib, a PI3Kα Inhibitor, in Patients with Metastatic Uveal Melanoma.
- Published in:
- Cancers, 2021, v. 13, n. 21, p. 5504, doi. 10.3390/cancers13215504
- By:
- Publication type:
- Article
IGF-1R/mTOR Targeted Therapy for Ewing Sarcoma: A Meta-Analysis of Five IGF-1R-Related Trials Matched to Proteomic and Radiologic Predictive Biomarkers.
- Published in:
- Cancers, 2020, v. 12, n. 7, p. 1768, doi. 10.3390/cancers12071768
- By:
- Publication type:
- Article
Study design and rationale for a randomised, placebo-controlled, doubleblind study to assess the efficacy of selumetinib (AZD6244; ARRY-142886) in combination with dacarbazine in patients with metastatic uveal melanoma (SUMIT).
- Published in:
- BMC Cancer, 2015, v. 15, n. 1, p. 1, doi. 10.1186/s12885-015-1470-z
- By:
- Publication type:
- Article
Study design and rationale for a randomised, placebo-controlled, double-blind study to assess the efficacy of selumetinib (AZD6244; ARRY-142886) in combination with dacarbazine in patients with metastatic uveal melanoma (SUMIT).
- Published in:
- 2015
- By:
- Publication type:
- journal article
A phase I clinical trial of FOLFIRI in combination with the pan-cyclin-dependent kinase (CDK) inhibitor flavopiridol.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 6, p. 1113, doi. 10.1007/s00280-010-1269-1
- By:
- Publication type:
- Article